This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Cracking the Diverse Biologic Code of Diffuse Larg...
Journal

Cracking the Diverse Biologic Code of Diffuse Large B-Cell Lymphoma

Read time: 1 mins
Published:25th Mar 2020

The majority of patients with diffuse large B-cell lymphoma (DLBCL) will be cured with frontline combination therapy. Thus, research is focused on “cracking the code” of the diverse biologic mechanisms that confer drug resistance. Profound molecular complexity exists across cases of DLBCL indicating this general histological category is imprecise and includes multiple disease entities.

Read abstract on library site